Home Recalls D-1436-2014
Class III · Low risk Terminated Initiated Jun 17, 2014 (12 years ago)
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Impurities/Degradation Specifications: out of specification impurity test results.
What was recalled
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Recalling firm Teva Pharmaceuticals USA
NDC code 0555-9043-58
Origin PA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1436-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing May 27, 2026
Reason Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Class II · Moderate risk Ongoing May 12, 2026
Reason Defective Container; packets were found to be either empty or partially full.
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter